In early 2022, Stanford medical student Santiago Sanchez set out to organize a campus debate with Jay Bhattacharya — a professor at the university whose outspoken denunciations of pandemic lockdowns ...

George Tidmarsh left the agency amid accusations of misusing his authority and after clashing with another top official.

In other news, the FDA moves to restrict use of fluoride supplements by children and the EPA approves more pesticides that some consider PFAS ...

Dr George Tidmarsh resigned after he was placed on administrative leave during an investigation into comments he made about a drug.

I am calling for Dr. Vinay Prasad to manage the FDA in a mature, professional, competent, transparent manner.  That’s just the bare minimum, and yet, he can’t even manage that.

Federal budget cuts pose a threat to progress that has improved lung cancer survival, according to the American Lung ...

The search continues for a new leader for the FDA’s Center for Drug Evaluation and Research after George Tidmarsh resigned on ...

Reports suggest that, internally, the Food and Drug Administration is facing a crisis of confidence. Kennedy's reign has been ...

This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating a 34-day-plus record set ...

Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...

In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator, ...

The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...